For example, the expression of GATA2 in human and mouse lung tumors were distinctly downregulated compared with normal lung tissues and its further suppression was not an effective treatment for KRAS mutant lung cancer 12, while GATA2 was essential for survival of KRAS mutant NSCLC cells 13. This evidence concerns the gene KRAS and lung cancer.